Helicobacter pylori: Recent advances in the study of its pathogenicity and prevention

Salud Publica de Mexico

Volumn 43, Issue 3, 2001, Pages 237-247

  Aguilar, Germán R ^a   Ayala, Guadalupe ^a   Fierros Zárate, Geny ^a  

^a INSTITUTO NACIONAL DE SALUD PÚBLICA   (Mexico)

Author keywords

Gastric cancer; Helicobacter pylori; Vaccination

Indexed keywords

UREASE;

BACTERIAL INFECTION; BACTERIAL VIRULENCE; CHRONIC GASTRITIS; DISEASE ASSOCIATION; DUODENUM ULCER; HELICOBACTER PYLORI; HUMAN; NONHUMAN; PATHOGENICITY; REVIEW; STOMACH CANCER; VACCINATION;

EID: 0034929354     PISSN: 00363634     EISSN: None     Source Type: Journal    
DOI: 10.1590/S0036-36342001000300010     Document Type: Review

References (139)

1. Helicobatter pylori virulence and genetic geography
2. Unidentified curved bacilli on gastric epithelium in active chronic gastritis
3. Original isolation of Campylobacter pyloridis from human gastric mucosa
4. How does Helicobacter pylori cause mucosal damage? The inflammatory response
5. Are all Helicobacters equal? Mechanisms of gastroduodenal pathology and their clinical implications
6. Association of Helicobacter pylori with gastroduodenal diseases
7. Attempt to fulfill Koch's postulates for pyloric Campylobacter
8. Ingestion of Campylobacter pylori causes gastritis and raised fasting pH
9. Long-term follow-up of voluntary ingestion of Helicobacter pylori
10. Clinical expressions of Helicobacter pytori infection
11. Helicobacter pylori and ulcerogenesis
12. Helicobacter pylori infection and the risk of gastric adenocarcinoma
13. Helicobacter pylori infection and gastric carcinoma among Japanese Americans in Hawaii
14. Association of Helicobocter pylori infection with gastric cancer
15. Helicobacter pylori and gastric cancer - The clinicians' point of view
16. Helicobacter pylori and gastric lymphoma
17. What role does Helicobocter pylori play in dyspepsia and nonulcer dyspepsia? Arguments for and against H. pylori being associated with dyspeptic symptoms
18. Helicobacter pylori: The size of the problem
19. Helicobacter pylori and gastric cancer
20. Compylobacter pyloridis and acid-induced gastric metaplasia in the pathogenesis of duodenitis
21. Study of Helicobacter pylori colonization of patches of heterotopic gastric mucosa (HGM) at the upper esophagus
22. Gastric and esophageal Campylobacter pylori in patients with Barrett's esophagus
23. Campylobacter pylori infection in Meckel's diverticula containing gastric mucosa
24. Campylobacter pylori colonizing heterotopic gastric tissue in the rectum
25. Extraintestinal pathology associated with Helicobacter infection
26. Non-gastrointestinal tract associations of Helicobacter pylori infection
27. Helicobacter pylori. One bacterium and a broad spectrum of human disease! An overview
28. Biological sex as a risk factor for Helicobacter pylori infection in healthy young adults
29. Epidemiology and genetics of peptic ulcer
30. Clinical relevance of the Helicobacter pylori gene for blood-group antigen-binding adhesin
31. Local acid production and Helicobacter pylori: A unifying hypothesis of gastro-duodenal disease
32. Epidemiology of, and risk factors for, Helicobacter pylori infection among 3194 asymptomatic subjects in 17 populations
33. The epidemiology of stomach cancer: Correlating the past with the present. Socioeconomic influences in early life can influence mortality in adult life
34. Campylobacter pylori, NSAIDs and smoking: Risk factors for peptic ulcer disease
35. Is gastric carcinoma an infectious disease!
36. Epidemiological study on food intake and Helicobacter pylori infection
37. Alcohol consumption and Helicobacter pylori infection: Results from the German National Health and Nutrition Survey
38. A case-control study of gastric cancer and diet in Italy: II. Association with nutrients
39. An investigation into factors associated with Helicobacter pylori infection
40. Epidemiological features of Helicobacter pylori infection in developing countries
41. The cohort effect and Helicobacter pylori
42. Seroprevalence of Helicobacter pylori in Seventh-Day Adventists and other groups in Maryland. Lack of association with diet
43. Seroprevalence of Helicobacter pylori infection in a cohort of US Army recruits
44. Seroprevalence and associated risk factors of Helicobacter pylori infection in Taiwan
45. The prevalence of Helicobacter pylori-positive serology in asymptomatic children
46. A study of twins. Helicobacter pylori infection: Genetic and environmental influences
47. The prevalence of Helicobacter pylori infection among inhabitants and healthy employees of institutes for the intellectually disabled
48. Helicobacter pylori infection in the Colombian Andes: A population-based study of transmission pathways
49. Familial clustering of Helicobacter pylori infection: Population-based study
50. Routes of transmission of Helicobacter pylori infection
51. Patient-to-patient transmission of Campylobacter pylori infection by fiberoptic gastroduodenoscopy and biopsy
52. Non-human reservoirs of Helicobacter pylori
53. New acquisitions in Helicobacter pylori characteristics
54. Essential role of urease in pathogenesis of gastritis induced by Helicobacter pylori in gnotobiotic piglets
55. Molecular cloning and characterization of the Helicobacter pylori fliD gene, an essential factor in flagellar structure and motility
56. Biochemical aspects of Helicobacter pylori colonization of the human gastric mucosa
57. Haemagglutination profiles of Helicobacter species that cause gastritis in man and animals
58. The complete genome sequence of the gastric pathogen Helicobacter pylori
59. Metabolism and genetics of Helicobacter pylori: The Genome Era
60. Mechanisms of Helicobacter pylori infection: Bacterial factors
61. Helicobacter pylori lipopolysaccharide-mediated gastric and extragastric pathology
62. Low biological activity of Helicobacter pylori lipopolysaccharide
63. Immunological activity of lipopolysaccharide of Helicobacter pylori on human peripheral mononuclear cells in comparison to lipopolysaccharides of other intestinal bacteria
64. Helicobacter pylori lipopolysaccharide binds to CD14 and stimulates release of interleukin-8, epithelial neutrophil-activating peptide 78, and monocyte chemotactic protein I by human monocytes
65. Molecular mimicry between Helicobacter pylori and the host
66. The gastric H+, K+-ATPase is a major autoantigen in chronic Helicobacter pylori gastritis with body mucosa atrophy
67. Bacterial factors and immune pathogenesis in Helicobacter pylori infection
68. Cytotoxic activity in broth-culture filtrates of Campylobacter pylori
69. Cytotoxin production by Campylobacter pylori strains isolated from patients with peptic ulcers and from patients with chronic gastritis only
70. Purification and characterization of the vacuolating toxin from Helicobacter pylori
71. Gene structure of the Helicobacter pylori cytotoxin and evidence of its key role in gastric disease
72. Montecucco C. Vacuoles induced by Helicobacter pylori toxin contain both late endosomal and lysosomal markers
73. Towards deciphering the Helicobacter pylori cytotoxin
74. Effect of Helicobacter pylori vacuolating toxin on maturation and extracellular release of procathepsin D and on epidermal growth factor degradation
75. The m2 form of the Helicobacter pylori cytotoxin has cell type-specific vacuolating activity
76. Activation of Helicobacter pylori VacA toxin by alkaline or acid conditions increases its binding to a 250-kDa receptor protein-tyrosine phosphatase beta
77. Mosaicism in vacuolating cytotoxin alleles of Helicobacter pylori. Association of specific vacA types with cytotoxin production and peptic ulceration
78. Expanding allelic diversity of Helicobacter pylori vacA
79. Colonization of Mexican patients by multiple Helicobacter pylori strains with different vacA and cagA genotypes
80. Clinical and pathological importance of heterogeneity in vacA, the vacuolating cyto-toxin gene of Helicobacter pylori
81. VacA genotypes and genetic diversity in clinical isolates of Helicobacter pylori
82. Analysis and typing of the vacA gene from cagA-positive strains of Helicobacter pylori isolated in Japan
83. Helicobacter pylori cagA status, vacA genotypes and ulcer disease
84. Heterogeneity in the Helicobacter pylori vacA and cagA genes: Association with gastroduodenal disease in South Africa?
85. Analysis of Helicobacter pylori vacA and cagA genotypes and serum antibody profile in benign and malignant gastroduodenal diseases
86. Typing of Helicobacter pylori vacA gene and detection of cagA gene by PCR and reverse hybridization
87. Identification and analysis of a new vacA genotype variant of Helicobacter pylori in different patient groups in Germany
88. Major virulence factors. VacA and CagA, are commonly positive in Helicobacter pylori isolates in Japan
89. Helicobacter pylori cagA status and s and m alleles of vacA in isolates from individuals with a variety of H. pylori-associated gastric diseases
90. Single-step PCR amplification and enzyme restriction analysis of the entire Helicobacter pylori cytotoxin vacA gene for genetic variability studies
91. Heterogeneity in levels of vacuolating cytotoxin gene (vacA) transcription among Helicobacter pylori strains
92. Translocation of Helicobacter pylori CagA into gastric epithelial cells by type IV secretion
93. Analysis of expression of CagA and VacA virulence factors in 43 strains of Helicobacter pylori reveals that clinical isolates can be divided into two major types and that CagA is not necessary for expression of the vacuolating cytotoxin
94. H. pylori virulence factors
95. cag, a pathogenicity island of Helicobacter pylori, encodes type 1-specific and disease-associated virulence factors
96. Helicobacter pylori physiology predicted from genomic comparison of two strains
97. The interrelationship between cytotoxin-associated gene A, vacuolating cytotoxin, and Helicobacter pylori related diseases
98. Molecular characterization of the 128-kDa immunodominant antigen of Helicobacter pylori associated with cytotoxicity and duodenal ulcer
99. Helicobacter pylori induced interleukin-8 expression in gastric epithelial cells is associated with CagA positive phenotype
100. CagA/ cytotoxic strains of Helicobacter pylori and interleukin-8 in gastric epithelial cell lines
101. Helicobacter pylori and atrophic gastritis: Importance of the cagA status
102. Serologic detection of infection with cagA+ Helicobacter pylori strains
103. Infection with Helicobacter pylori strains possessing cagA is associated with an increased risk of developing adenocarcinoma of the stomach
104. Development of a mouse model of Helicobacter pylori infection that mimics human disease
105. Structure of cag pathogenicity island in Japanese Helicobacter pylori isolates
106. Analyses of the cag pathogenicity island of Helicobacter pylori
107. Helicobacter pylori picB, a homologue of the Bordetella pertussis toxin secretion protein, is required for induction of IL-8 in gastric epithelial cells
108. Genomic-sequence comparison of two unrelated isolates of the human gastric pathogen Helicobacter pylori
109. Agrobacterium tumefaciens T-Complex Transport Apparatus: A paradigm for a new family of multifunctional transporters in eubacteria
110. Mutants in the pt/A-H genes of Bordetella pertussis are deficient for pertussis toxin secretion
111. Interaction between the F plasmid TraA (F-pilin) and TraQ proteins
112. A homologue of the Agrobacterium tumefaciens VirB and Bordetella pertussis Ptl type IV secretion systems is essential for intracellular survival of Brucella suis
113. Activation of activator protein I and stress response kinases in epithelial cells colonized by Helicobacter pylori encoding the cag pathogenicity island
114. Mutation of the cytotoxin-associated cagA gene does not affect the vacuolating cytotoxin activity of Helicobacter pylori
115. Interleukin-8 response of gastric epithelial cell lines to Helicobacter pylori stimulation in vitro
116. Induction of host signal transduction pathways by Helicobacter pylori
117. Inflammatory mediators in gastroenterology. Overview
118. A secreted/shed product of Helicobacter pylori activates transcription factor nuclear factor-kappa B
119. I kappa B: A specific inhibitor of the NF-kappa B transcription factor
120. Proteins encoded by the cag pathogenicity island of Helicobacter pylori are required for NF-kappaB activation
121. Differential activation of mitogen-activated protein kinases in AGS gastric epithelial cells by cag+ and cag- Helicobacter pylori
122. Contributions of genome sequencing to understanding the biology of Helicobacter pylori
123. Consensus conference. Medical treatment of peptic ulcer disease. Practice guidelines
124. Resistance of Helicobacter pylori to antibiotics
125. Eradication of chronic Helicobacter pylori infection by therapeutic vaccination
126. Host response and vaccine development to Helicobacter pylori infection
127. Therapeutic intragastric vaccination against Helicobacter pylori in mice eradicates an otherwise chronic infection and confers protection against reinfection
128. Therapeutic immunization against Helicobacter pylori infection
129. Oral immunization with Helicobacter pylori urease B subunit as a treatment against Helicobacter infection in mice
130. Protection against Helicobacter pylori infection in mice by intragastric vaccination with H. pylori antigens is achieved using a non-toxic mutant of E. coli heat-labile enterotoxin (LT) as adjuvant
131. Catalase, a novel antigen for Helicobacter pylori vaccination
132. Therapeutic immunization against Helicobacter mustelae in naturally infected ferrets
133. Host specificity of Helicobacter pylori strains and host responses in experimentally challenged nonhuman primates
134. A genetically detoxified derivative of heat-labile Escherichia coli enterotoxin induces neutralizing antibodies against the A subunit
135. A nontoxic mutant of cholera toxin elicits Th2-type responses for enhanced mucosal immunity
136. Th1/Th2 cells
137. Differential stimulation of interleukin-12 (IL-12) and IL-10 by live and killed Helicobacter pylori in vitro and association of IL-12 production with gamma interferon-producing T cells in the human gastric mucosa
138. Naturally acquired human immune responses against Helicobacter pylori and implications for vaccine development
139. Local and systemic antibody responses in humans with Helicobacter pylori infection